⚠ The Conglomerate Discount Is RealModerate threat

Even if the synergies partly materialize, PZU faces the stubborn verdict markets pass on financial conglomerates: the conglomerate discount. Sprawling groups spanning banking and insurance routinely trade for less than the sum of their parts would fetch separately, because investors distrust the complexity, struggle to value the opaque cross-holdings, and doubt that head office allocates capital better than the market would. A focused insurer and a focused bank are each easier to understand, value, and hold than one tangled entity that is neither.

For PZU shareholders this is a live cost, not a theoretical one. Part of the perennially low multiple the group trades at is the market refusing to pay full price for a complicated, state-run financial conglomerate, and the Pekao merger — by making the group larger and more complex, not simpler — could entrench that discount rather than cure it. The bull case says the merger unlocks value that closes the discount; the bear case says it deepens the very complexity that causes it. Which proves right will show up, over years, in whether the combined group's valuation converges toward its focused peers or stays stuck below them — the sub-10x multiple is the baseline to beat¹.